Company: HURA
Filing Date: 2025-11-03
Form Type: S-3
Source: 0001193125-25-262843
Chunk: 42

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-11-03
Form: S-3
Chunk 42
---
uniary interests therein. See “Principal Stockholders” 
 for additional information regarding the beneficial ownership of Samir Patel.                                                                                                                                                                |

| (17) | The securities reported are held by Paulson Investment Company, LLC (“Paulson”). Malcolm Alexander                                                                                                                                                
 Winks directly has the power to vote or dispose of the securities reported and may be deemed to the beneficial owner thereunder. Malcolm Alexander Winks disclaims beneficial ownership of these securities except to the extent of his pecuniary 
 interests therein.                                                                                                                                                                                                                                |

32

PLAN OF DISTRIBUTION

We may sell securities in any one or more of the following ways from time to time: (i) through agents; (ii) to or through
underwriters; (iii) through brokers or dealers; (iv) directly by us to purchasers, including through a specific bidding, auction or other process; (v) through the distribution of subscription rights; (vi) in “at the
market,” equity line or similar offerings to or through a market maker or into an existing trading market, or a securities exchange or otherwise; or (vii) through a combination of any of these methods of sale. The applicable prospectus
supplement and/or other offering material will contain the terms of the transaction, name or names of any underwriters, dealers, or agents and the respective amounts of securities underwritten or purchased by them, the initial public offering price
of the securities, and the applicable agent’s commission, dealer’s purchase price or underwriter’s discount. Any dealers and agents participating in the distribution of the securities may be deemed to be underwriters, and
compensation received by them on resale of the securities may be deemed to be underwriting discounts.

Any initial offering price, dealer
purchase price, discount or commission may be changed from time to time.

The securities may be distributed from time to time in one or
more transactions, at negotiated prices, at a fixed price or fixed prices (that may be subject to change), at market prices prevailing at the time of sale, at various prices determined at the time of sale or at prices related to prevailing market
prices.

Offers to purchase securities may be solicited directly by us or by agents designated by us from time to time. Any such agent may
be deemed to be an underwriter, as that term is defined in the Securities Act, of the securities so offered and sold.

If underwriters are
utilized in the sale of any securities in respect of which this prospectus is being delivered, such securities will be